GlaxoSmithkline Consumer Healthcare – Margin will be around 18%
Highlights of the call The company’s sales for the quarter ended March 09 has increased by 31% to Rs 539.37 crore, supported by volume growth in Horlick by 21% and Boost by 8%. There was a overall volume growth of 20%. There was a price growth of around 7% for the quarter. A 3% excise … Read more GlaxoSmithkline Consumer Healthcare – Margin will be around 18%